Deciphering the gut microbiota's (Coprococcus and Subdoligranulum) impact on depression: Network pharmacology and molecular dynamics simulation
Pharmacology Biochemistry and Behavior,
Journal Year:
2024,
Volume and Issue:
241, P. 173805 - 173805
Published: June 5, 2024
Language: Английский
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis
Tingting Luo,
No information about this author
Qingya Che,
No information about this author
Ziyi Guo
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 9, 2024
The
gut
microbiota
offers
numerous
benefits
to
the
human
body,
including
promotion
of
nutrient
absorption,
participation
in
metabolic
processes,
and
enhancement
immune
function.
Recent
studies
have
introduced
concept
gut-organ
axis,
which
encompasses
interactions
such
as
gut-brain
gut-liver
gut-lung
axis.
This
underscores
complex
interplay
between
various
organs
tissues,
brain,
heart,
lungs,
liver,
kidneys,
muscles,
bones.
Growing
evidence
indicates
that
can
influence
onset
progression
multi-organ
system
diseases
through
their
effects
on
Traditional
Chinese
medicine
has
demonstrated
significant
efficacy
regulating
gastrointestinal
system,
leveraging
its
unique
advantages.
Considerable
advancements
been
made
understanding
role
axis
within
mechanisms
action
traditional
medicine.
review
aims
elucidate
roles
health,
explore
potential
connections
microbiota,
examine
therapeutic
microbiota-gut-organ
Furthermore,
addresses
limitations
challenges
present
current
research
while
proposing
directions
for
future
investigations
this
area.
Language: Английский
Exploring the Role of Gut Microbiota in Depression: Pathogenesis and Therapeutic Insights
Asian Journal of Psychiatry,
Journal Year:
2025,
Volume and Issue:
105, P. 104411 - 104411
Published: Feb. 21, 2025
Language: Английский
Enterobacterial caseinolytic protease B (ClpB) and ClpB antibodies in adolescents with anorexia nervosa
Journal of Psychiatric Research,
Journal Year:
2025,
Volume and Issue:
184, P. 8 - 16
Published: Feb. 22, 2025
Language: Английский
Integrated network pharmacology, metabolomics, and microbiome studies to reveal the therapeutic effects of Anacyclus pyrethrum in PD–MCI mice
Tayier Tuersong,
No information about this author
Qian Wu,
No information about this author
Yan Chen
No information about this author
et al.
Phytomedicine,
Journal Year:
2025,
Volume and Issue:
142, P. 156729 - 156729
Published: April 12, 2025
Anacyclus
pyrethrum
(l.)
DC
has
potential
value
in
treating
Parkinson's
disease
(PD)-mild
cognitive
impairment
(MCI),
manifesting
as
impaired
memory,
attention,
executive
function,
and
language.
However,
the
specific
targets
modes
of
action
A.
remain
unclear.
The
aim
this
study
was
to
identify
active
components
examine
their
effectiveness
a
mouse
model
PD-MCI.
We
generated
ethanol
extracts
root
(EEAP)
identified
its
related
using
UHPLC-MS/MS
network
pharmacology.The
PD-MCI
induced
via
intraperitoneal
administration
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP).
After
following
continuous
EEAP,Altered
learning
or
well
anxiety,
were
tested
morris
water
maze,
eight-arm
radial
arm
maze
(RAM),
open-field
test,elevated
plus-maze.
Brain
histopathology
ultrastructural
changes
examined
brightfield
microscopy,
electron
respectively.
Furthermore,
protein
expression
assessed
western
blotting.Stool
samples
used
for
metabolomics
analysis
by
16S
rDNA
sequencing
determine
compositional
gut
microbiota.We
conducted
short-chain
fatty
acid
targeted
experiment
role
gut-brain
axis
Using
UPLC-MS-MS,
126
compounds
from
samples.After
searching
databases
literature
reports,
31
544
drug-disease
screened.
Biological
processes
molecular
functions,
such
energy
channels,
cell
signaling,
metabolism,
discovered
through
GO
analysis.
showed
that
average
swimming
distance
escape
latency
mice
EEAP
groups
decreased.
had
much
higher
number
errors
working
memory
than
control
mice.
In
open
field
experiment,
compared
with
group,
group
exhibited
an
increase
movement
speed
total
distance,
along
decrease
residence
time.In
elevated
plus
less
anxiety
Model.
Donepezil/Levodopa(D/l)
mitigated
anxiety-like
behavior,
(100-400
mg/kg)
dose-dependent
open-arm
metrics,
suggesting
it
may
ease
mice.Hippocampal
tissue
treated
different
doses
intact
cellular
layers
hematoxylin-eosin-stained
cones
slightly
better;cells
arranged
neatly;
morphology
normal,
distributed
uniformly.
Electron
microscopy
revealed
nuclear
membrane,
chromatin,
nucleoli
clearly
demarcated
hippocampus
EEAP,
contrary
group.
brain
lighter
thinner
bands
amyloid
precursor
(APP)
Aβ
observed
those
mice,
APP
blank
shown
stronger
bands.
EEAP-treated
weaker,
indicating
reduced
expression.
lower
Bcl-2
Bax
levels.
treatment
increased
decreased
expression.Compared
substantially
low
glutathione
peroxidase
(GSH-Px),superoxide
dismutase(SOD),catalase
(CAT)activity
(p
<
0.05),much
0.05)
EEAP-H
model.
intervention
significantly
modulated
fecal
metabolic
profile
abundance
steroid
lipid
metabolites,
including
linoleylethanolamine,
markedly
altered
reversing
several
these
abnormalities.
PLS-DA
OPLS-DA
significant
separation
between
(Q2=
0.542,
p
0.01),
confirming
effect.
Random
forest
15
key
markers,
d-glutamine
hydrocodone.
Metabolic
pathway
demonstrated
enrichment
phenylalanine,
tyrosine,
tryptophan
arginine
biosynthesis
pathways
0.05).
Support
Vector
Machine
(SVM)
achieved
AUC
approaching
1,
substantial
differences
metabolite
profiles.
influenced
composition
functional
intestinal
microbiota.
Venn
diagram
illustrates
each
shared
342
operational
taxonomic
units
(OTUs),
400
exhibiting
distinct
Bacteroidetes
proportion.
LEfSe
g_Prevotella
characteristic
bacterium
c_Epsilonproteobacteria
g_Adlercreutzia
100
Faith's
Phylogenetic
Diversity
(PD)
index
highest
Non-metric
Multidimensional
Scaling
(NMDS)/Principal
Coordinates
Analysis
(PCoA)
microbial
community
structure.
Short-chain
acids
(SCFAs)
indicated
acetic
predominant
metabolite,
while
dose-dependently
regulated
propionic
isovaleric
levels
(VIP
>
0.001).
These
findings
demonstrate
exerts
regulatory
effects
reshaping
structure
functions
holds
great
promise
therapeutic
agent
PD-MCI,
exerting
multiple
mechanisms,
regulating
expression,
modulating
profile,
microbiota
metabolites.
Language: Английский
Potential causal association between the oral microbiome and bipolar disorder
Jing Li,
No information about this author
Jun Chen,
No information about this author
Jiwen Li
No information about this author
et al.
Journal of Affective Disorders,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Language: Английский
Advancing microbiota therapeutics: the role of synthetic biology in engineering microbial communities for precision medicine
Asiya Nazir,
No information about this author
Fathima Hasnain Nadeem Hussain,
No information about this author
Afsheen Raza
No information about this author
et al.
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2024,
Volume and Issue:
12
Published: Dec. 4, 2024
Over
recent
years,
studies
on
microbiota
research
and
synthetic
biology
have
explored
novel
approaches
microbial
manipulation
for
therapeutic
purposes.
However,
fragmented
information
is
available
this
aspect
with
key
insights
scattered
across
various
disciplines
such
as
molecular
biology,
genetics,
bioengineering,
medicine.
This
review
aims
to
the
transformative
potential
of
in
advancing
microbiome
therapies,
significant
implications
healthcare,
agriculture,
environmental
sustainability.
By
merging
computer
science,
engineering,
allows
precise
design
modification
biological
systems
via
cutting
edge
technologies
like
CRISPR/Cas9
gene
editing,
metabolic
oligonucleotide
synthesis,
thus
paving
way
targeted
treatments
personalized
probiotics
engineered
microorganisms.
The
will
also
highlight
vital
role
gut
disorders
caused
by
its
dysbiosis
suggesting
microbiota-based
therapies
innovations
biosensors
real-time
health
monitoring,
non-invasive
diagnostic
tools,
automated
bio
foundries
better
outcomes.
Moreover,
challenges
including
genetic
stability,
safety,
robust
regulatory
frameworks
be
discussed
understand
importance
ongoing
ensure
safe
effective
interventions.
Language: Английский
Comparative Analysis of Fecal Microbiota Between Adolescents with Early-Onset Psychosis and Adults with Schizophrenia
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(10), P. 2071 - 2071
Published: Oct. 16, 2024
Studies
of
the
composition
gut
microbiome
have
consistently
shown
that
psychiatric
disorders
such
as
schizophrenia
are
associated
with
dysbiosis.
However,
research
focusing
on
adolescents
early-onset
psychosis
remains
limited.
This
study
aimed
to
characterize
microbial
communities
and
their
potential
metabolic
functions
in
these
populations.
We
identified
genera
Language: Английский
Effects of Synbiotic Supplementation on Bone and Metabolic Health in Caucasian Postmenopausal Women: Rationale and Design of the OsteoPreP Trial
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(23), P. 4219 - 4219
Published: Dec. 6, 2024
Correction
of
decreased
diversity
the
gut
microbiome,
which
is
characteristic
menopause,
by
supplementation
with
a
synbiotic
may
attenuate
or
prevent
dysbiosis
processes
and
preserve
bone
mass.
We
describe
rationale
design
OsteoPreP
trial
aimed
at
evaluating
effects
12
months
on
metabolic
health
in
postmenopausal
Caucasian
women.
Language: Английский
To be or not to be manipulated by our bacteria?
Marc Le Borgne,
No information about this author
Marc Le Borgne,
No information about this author
Kézia Sossou-Echavidre
No information about this author
et al.
Published: Dec. 23, 2024
The
gut
microbiota
has
become
a
central
focus
of
research
since
its
intricate
connection
with
the
brain
was
identified.
Notably,
can
influence
mental
health,
opening
new
prospects
for
improving
management
psychiatric
disorders.
Understanding
bidirectional
interactions
between
brain,
gut,
and
microbiome
is
crucial
evaluating
true
impact
on
health
subsequent
implications
psychiatry.
Currently,
brain-gut-microbiome
axis
communicates
through
five
interconnected
pathways:
immune
system,
vagus
nerve,
enteric
nervous
neuroendocrine
circulatory
system.
development
microbiota-based
therapeutics
signals
significant
changes
in
current
clinical
practices.
Furthermore,
microbiome-based
are
expected
to
undergo
substantial
regulatory
transformations
Europe
coming
years.
This
mini-review
aims
explore
these
aspects
evaluate
potential
bacteria
shape
interventions.
Language: Английский